EUVIMEDEUVIMED entdecken
Kohortenstudie

Optimal Duration of Dual Antiplatelet Therapy After Carotid Artery Stenting: A Nationwide Cohort Study

Joonsang Yoo iD, Hyunsun Lim iD, Kwon-Duk Seo iD

Stroke · 2025-03 · 56 (3) · 613-620

DOI: 10.1161/strokeaha.124.048743 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Stroke, 2025-03. Verfasst von Joonsang Yoo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Korea (J.Y.). Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Carotid Stenosis, Stents, Dual Anti-Platelet Therapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Carotid artery stenting (CAS) is an alternative treatment for patients with carotid artery stenosis who are not eligible for carotid endarterectomy. Dual antiplatelet therapy (DAPT) after CAS aims to prevent ischemic stroke. However, its optimal duration remains unclear. We aimed to determine the optimal duration of DAPT by identifying the differences in clinical events that occur depending on the DAPT maintenance period. METHODS: Data were obtained from the nationwide database of the Korean Health Insurance Review and Assessment Service between 2007 and 2019. Patients who received CAS, as identified by procedure codes, were divided into 2 groups according to the duration of DAPT (aspirin and clopidogrel): those who maintained DAPT for at least 90 days but for

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsCarotid StenosisStentsDual Anti-Platelet TherapyAspirinClopidogrelIschemic StrokeHumansMaleFemaleAgedMiddle AgedRepublic of KoreaCohort StudiesAged, 80 and overTreatment OutcomeEndarterectomy, Carotid

Stichwörter der Autor:innen

carotid arteryendarterectomy, carotidintracranial hemorrhageischemic strokestents

Substanzen

Platelet Aggregation InhibitorsAspirinClopidogrel

Autor:innen und Institutionen

  • Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Korea (J.Y.).
  • Department of Research and Analysis (H.L.), National Health Insurance Service Ilsan Hospital, Goyang, Korea.
  • Department of Neurology (K.-D.S.), National Health Insurance Service Ilsan Hospital, Goyang, Korea.
  • Department of Neurology, Graduate School of Medicine, Kangwon National University, Chuncheon, Korea (K.-D.S.).
  • Now with Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea (K.-D.S.).

ORCID-Profile: Joonsang Yoo, Hyunsun Lim, Kwon-Duk Seo

Zitieren

APA

Yoo, J., Lim, H., & Seo, K. D. (2025). Optimal Duration of Dual Antiplatelet Therapy After Carotid Artery Stenting: A Nationwide Cohort Study. Stroke, 56(3), 613-620. https://doi.org/10.1161/strokeaha.124.048743

Vancouver

Yoo J, Lim H, Seo KD. Optimal Duration of Dual Antiplatelet Therapy After Carotid Artery Stenting: A Nationwide Cohort Study. Stroke. 2025;56(3):613-620. doi:10.1161/strokeaha.124.048743

BibTeX
@article{Yoo2025,
  author = {Yoo, Joonsang and Lim, Hyunsun and Seo, Kwon-Duk},
  title = {Optimal Duration of Dual Antiplatelet Therapy After Carotid Artery Stenting: A Nationwide Cohort Study},
  journal = {Stroke},
  year = {2025},
  volume = {56},
  number = {3},
  pages = {613--620},
  doi = {10.1161/strokeaha.124.048743}
}
Kostenlos starten →